DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer’s Disease.

Madrid, A., K. Hogan, L. Papale, L. Clark, S. Asthana, S. Johnson, and R. Alisch. “DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer’s Disease.”. Journal of Alzheimer’s Disease : JAD, Vol. 66, no. 3, 2018, pp. 927-34.

Differentially methylated positions (DMPs) between persons with and without late-onset Alzheimer’s disease (LOAD) were observed at 477 of 769,190 loci in a plurality of genes. Of these, 17 were shared with DMPs identified using clinical LOAD markers analyzed independently as continuous variables comprising Rey Auditory Verbal Learning Test scores, cerebrospinal fluid total tau (t-tau) and phosphorylated tau 181 (p-tau181) levels, and t-tau/Aβ1-42 (Aβ42), p-tau181/Aβ42, and Aβ42/Aβ1-40 (Aβ40) ratios. In patients with LOAD, 12 of the shared 17 DMPs were hypomethylated in B3GALT4 (Beta-1,3-galatcosyltransferase 4) (EC 2.4.1.62), and 5 were hypomethylated in ZADH2 (Prostaglandin reductase 3) (EC 1.3.1.48).

DOI: 10.3233/JAD-180592

PubMed: 30372681